Use of Anti – VEGF Therapy for ROP: When and How

Related

• 

  Fluorescein Angiographic Evaluation of Peripheral Retinal Vasculature After Ranubizumab Injection for Type I Retinopathy of Prematurity

  Clio Armitage Harper, MD

  Annual Meeting Talks

  2016

• 

  Percentage of Patients Maintained on Quarterly Anti-VEGF Dosing for the Treatment of Neovascular Age-Related Macular Degeneration

  David A. Eichenbaum, MD, FASRS

  Updates from the Field

  2018

• 

  Long-term Complications of Laser Treated Infants With Retinopathy of Prematurity

  Audina M. Berrocal, MD FASRS

  Annual Meeting Talks

  2020